Abstracts tagged "psoriasis and ultrasound"

Abstract Number: 147 • 2016 ACR/ARHP Annual Meeting
Ultrasonographic Evaluation of Subclinical Enthesitis in Patients with Psoriasis
Elzem Bolkan Günaydın¹, Perihan Aladağ², Duygu Tecer¹, Işıl Saadet Yenice¹, Esra Adışen² and Feride Nur Göğüş³, ¹Physical Medicine and Rehabilitation, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey, ²Dermatology, Faculty of Medicine, Gazi University, Ankara, Turkey, ³Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey
Background/Purpose: Psoriasis is a diseases with diverse skeletal manifestations of which enthesistis is the primary lesion. However, enthesitis may often develop without any symptoms or…
Abstract Number: 2739 • 2016 ACR/ARHP Annual Meeting
Subclinical Ungueal Distrophy in Patients with Psoriasis without Joint Involvement: Is There Any Role for Nail Ultrasound?
Barbara Nascimento de Carvalho Klemz¹, Karine Luz², Eugenia Maria Damasio Ohe³, Adriana Maria Porro⁴, Polianna de Oliveira Matos Soares⁵, Helder Henrique da Costa Pinheiro⁶ and Marcelo Pinheiro⁷, ¹Rheumatology Division, Federal University of Sao Paulo (Unifesp/ EPM), Sao Paulo, Brazil, ²Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil, ³Dermatology Division, Federal University of Sao Paulo, (UNIFESP/EPM), Sao Paulo, Brazil, ⁴Dermatology Division, Federal University of Sao Paulo (UNIFESP/EPM), Sao Paulo, Brazil, ⁵Federal University of Sao Paulo (UNIFESP/EPM), Sao Paulo, Brazil, ⁶Federal University of Para (UFPA), Belem, Brazil, ⁷Federal University of São Paulo, São Paulo, Brazil
Background/Purpose: The joint involvement is observed in approximately 30% of patients with psoriasis (Ps). However, no clinical, lab or by imaging strategy is well established…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].